Semafor reports FDA nominee Overton helped craft the case for cutting recommended childhood vaccines to 11
Heidi Overton, Trump's FDA nominee, helped craft the justification for cutting CDC-recommended childhood vaccines from 17 to 11, Semafor reported. The Senate health committee left without voting on her nomination, so confirmation falls to the lame-duck session.
Reality
- Evidence40
- Adoption
- Not scored
- Hype gap
- Not scored
- Incentives60
- Confidence45
Three former FDA chiefs say DOGE and Makary-era exits cost the agency knowledge it will take years to restore
Three former FDA chiefs said DOGE's 3,500 job cuts and a larger exodus under Marty Makary cost the agency institutional knowledge. Ned Sharpless said companies he works with now meet more junior reviewers.
Reality
- Evidence40
- Adoption
- Not scored
- Hype gap+30
- Incentives
- Not scored
- Confidence50
The United States is in its worst measles year since 1991. The figure on the federal counter is one death, marked subject to change, while Pennsylvania officials describe four deaths among unvaccinated people.
Reality
- Evidence55
- Adoption
- Not scored
- Hype gap+10
- Incentives
- Not scored
- Confidence50
Former FDA commissioners say China's scientific progress and faster trial start-up speed are driving more Phase 1 trials there than in the U.S.
Two former commissioners, writing before Heidi Overton's Senate hearing on Thursday, argue that FDA review capacity now decides where new medicines reach patients first. Their evidence is a count of trial starts.
Reality
- Evidence34
- Adoption33
- Hype gap+34
- Incentives76
- Confidence48
A policy aide, not a regulator: what Overton's FDA nomination changes for sponsors
Heidi Overton would arrive at the FDA from the White House Domestic Policy Council, with a political record rather than a regulatory one. Plan submissions for priorities set from outside the building.
Reality
- Evidence62
- Adoption
- Not scored
- Hype gap+15
- Incentives74
- Confidence55